A Randomized Two-Way Crossover, Single-Dose, Open-Label Study to Evaluate the Bioequivalence of a Test Formulation of KADIAN (2 x 10mg) Capsules Compared to a KADIAN 20 mg Capsule in Healthy Adult Subjects Under Fasted Conditions.
Phase of Trial: Phase I
Latest Information Update: 02 Sep 2009
At a glance
- Drugs Morphine (Primary)
- Indications Pain
- Focus Pharmacokinetics
- Sponsors Alpharma
- 02 Sep 2009 Primary outcome amended as reported by ClinicalTrials.gov.
- 10 Oct 2008 New trial record.